INmune Bio Inc. Common stock Stock Prediction
AI-powered sentiment analysis and prediction trends for INMB, updated each market day.
INMB AI Sentiment
AI sees no strong directional signal for INmune Bio Inc. Common stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About INmune Bio Inc. Common stock
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
Sector
Exchange
Market Cap
$34,029,130
Cap Tier
Employees
21
Headquarters
BOCA RATON, FL
Listed Since
Feb. 4, 2019
Website
INMB Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
INMB Volatility
INmune Bio Inc. Common stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
